Blog
03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox…
Research
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients with HIV (HIV R+) was safe and comparable to… - Blog
Defining the Goals of HIV Science Through 2034 10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical research enterprise. For more information, please… - Blog
Dr. Geri Donenberg Named NIH Associate Director for AIDS Research 09-19-2024Cross-posted from: NIH Office of the Director I am pleased to announce the selection of Geri R. Donenberg, Ph.D., as NIH Associate Director for AIDS Research… - Blog
ICYMI: Research Roundup from AIDS 2024 08-15-2024A brief roundup of key topics of HIV.gov’s coverage of AIDS 2024, including HIV prevention, cure research, and more. - Blog
Supporting Research for Older Adults Living with HIV 06-10-2024Cross-posted from: Inside NIA Blog During the early years of the AIDS epidemic four decades ago, life expectancy for a person diagnosed with HIV was just three… - Blog
An Emergency Department Screening Strategy Identifies Asymptomatic and Undiagnosed Syphilis 06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and… - Blog
FYI Video: A Conversation About the Importance of HIV Vaccine Research 06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH’s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for… - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can… - Blog
ICYMI: Research Roundup from CROI 2024 05-01-2024A quick roundup of key topics of HIV.gov’s coverage of the 2024 Conference on Retroviruses and Opportunistic Infections from HIV testing, treatment, and PrEP… - Blog
Routine Emergency Department Screening Reduces Congenital Syphilis: CROI 2024 Highlight 04-24-2024While at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) last month, HIV.gov discussed an innovative syphilis screening program that is… - Blog
Watch FYI Video with Community Advocate Raif Derrazi: CROI 2024 Reflections 04-12-2024In our latest FYI video, HIV community advocate Raif Derrazi shared his reflections on the 2024 Conference on Retroviruses and Opportunistic Infections (CROI)… - Blog
NIH Ending the HIV Epidemic Projects Bridge Gaps Between HIV Research and Public Health Practice (VIDEO) 04-09-2024Cross-posted from: NIAID Now Blog The National Institutes of Health recently issued $26M in awards to HIV research institutions in its fifth year supporting… - Blog
NIMH Reflects on Decades of Involvement in HIV Research 03-26-2024As part of a yearlong 75th anniversary celebration of transforming the understanding and treatment of mental illnesses, NIH’s National Institute of Mental… - Blog
Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV 03-06-2024Cross-posted from: NIH Newsroom Long-acting, injectable antiretroviral therapy (ART) suppressed HIV replication better than oral ART in people who had… - Blog
Children Surpass a Year of HIV Remission after Treatment Pause 03-06-2024Cross-posted from: NIH Newsroom Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused… - Blog
Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update from CROI 2024 03-06-2024On Tuesday at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with NIH’s Dr. Carl Dieffenbach about research on common… - Blog
NIAID’s Dr. Jeanne Marrazzo Previews CROI 2024 03-04-2024HIV.gov opened our coverage of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) today with a conversation with Jeanne Marrazzo, M.D., M… - Blog
Share Your Input on the Next NIH Strategic Plan for HIV Research by March 28 02-29-2024The NIH Office of AIDS Research (OAR) is seeking input to inform the development of the next multi-year NIH Strategic Plan for HIV and HIV-Related Research,… - Blog
Follow HIV.gov Next Week: Key HIV Research Updates from CROI 2024 02-27-2024Next week, HIV.gov will be sharing updates on the latest HIV research from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), taking…